Paravalvular Leak Closure Case Presentation

Slides:



Advertisements
Similar presentations
ICE ICE BABY !!!.
Advertisements

Mohammed Almansori MBBS, FRCPC Assistant Professor of Medicine & Interventional Cardiologist University of Dammam ECHO CLUB INVASIVE HEMODYNAMIC EVALUATION.
Mitral Valve Prosthesis. Types of mechanical valves:  Ball-cage valve (Starr-Edwards is the most common). - a spherical occluder is contained by metal.
Evaluation and Management of Asymptomatic Aortic Stenosis. Augusto Pichard, M.D. Director Innovation and Structural Heart Disease, Vice Chair, Medstar.
Trileaflet Aortic Valve. Management strategy for patients with chronic severe aortic regurgitation. Preoperative coronary angiography should be performed.
Right Ventricular Outflow Obstruction after Tetralogy of Fallot Repair Stephan Ziegeler, MD,* George J. Reul, MD,† Raymond F. Stainback, MD‡ *Department.
Case #1 Bicuspid Valve Dilated Aortic Root Mod AI/Mild AS - RW
Few Patients With Functional MR Are Treated Surgically: Duke Database Results Mitchell W. Krucoff MD FACC, FAHA, FSCAI Professor of Medicine /
TAVR Pearls Addressing the Shortcomings of the Current TAVR Generation
Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation Right Ventricular Function and Pulmonary Artery Hypertension After Degenerative.
Transhepatic venous cardiac catheterization
A shifting paradigm of care: Advances in transcatheter heart valve procedures Sandra Lauck MSN, RN, CCN(C) Clinical Nurse Specialist, Arrhythmia Management.
Transcatheter ASD closure, sans X-rays Peter Ewert MD Robert Beekman MD.
Siemens Acuson 3D TEE Bruce Bollen, MD Missoula Anesthesiology
Erle H. Austin, MD Kosair Children’s Hospital Louisville, Kentucky
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pediatric Cardiac Interventions J Am Coll Cardiol.
Adult Congenital Heart Disease Basic Teaching Course ACHD Curriculum: Case Lessons in Catheterization Percutaneous Treatment of Paravalvular Leaks Chad.
Thanks ………… Echocardiographic Evaluation Of Prosthetic Cardiac Valves Dr Gaurav Kumar Chaudhary MD,DM( Cardiology) Assistant Professor Department of Cardiology.
Longest Follow-up After Implantation of a Self-Expanding Repositionable Transcatheter Aortic Valve: Final Follow-up of the Evolut R CE Study Stephen Brecker,
Minimalist Approach to T-AVR
Carotid Access for TAVR: An underappreciated approach?
VSD post TAVR: Mechanisms, Presentation and Management
Disclosure Statement of Financial Interest Saibal Kar, MD, FACC
PERCUTANEOUS PULMONARY VALVE REPLACEMENT:
Ventricular Septal Defect Double Chamber RV (DCRV)
Extending the Boundaries of TAVR: Future Directions
MY WORST CASE OF THE YEAR
Challenging Case Presentation For Structural Heart Disease Program
Gates Vascular Institute
Is Transoesophageal Echocardiography during TAVR Essential?
Volume 1, Issue 2, Pages (April 2017)
Direct Flow Medical Experience with a Conformable, Repositionable, Retrievable, Percutaneous Aortic Valve Reginald Low MD University of California,Davis.
After a Successful TAVI
AORTIC STENOSIS.
30-Day Outcomes From John Webb, MD
Tips and Tricks for Safe Deployment of the Balloon Expandable Valve
TAVR – The Trans-carotid Approach
Case Demonstration: MitraClip Edge-to–Edge Repair
30-Day Safety and Echocardiographic Outcomes Following Transcatheter Aortic Valve Replacement with the Self-Expanding Repositionable Evolut PRO System.
Trans-Apical Aortic Valve Implant:
University of Cincinnati Medical Center
Guideliner related stent stripping
Early Outcomes with the Evolut R Repositionable Self-Expanding Transcatheter Aortic Valve in the United States Mathew Williams, MD, For the Evolut R US.
Alcohol Septal Ablation: Tips for Success
Table 1 : Baseline Characteristics
Direct Flow Medical Experience with a Conformable, Repositionable Retrievable Percutaneous Aortic Valve Reginald Low MD University of California, Davis.
Figure 1 Representative transoesophageal echocardiographic images of ventricular fibrillation during cardiopulmonary bypass. (A) Mid-oesophageal aortic.
A Step-by-Step Approach Using the Edwards SapienTransfemoral TAVI System E Murat Tuzcu Cleveland Clinic Disclosure: None.
Transcatheter Mitral Repair Complications & Bailout(s)
Managing and Correcting a "Frozen" Leaflet after TAVR
Contribution of Three-Dimensional Transesophageal Echocardiography to Diagnosis and Management of Thrombosis of a St. Jude Mechanical Prosthesis in the.
Progress Toward a Percutaneously Adjustable Mitral Ring: Micardia
Kyle D Buchanan, MD MedStar Washington Hospital Center
Groin Complication from Access Closure Failures
Fractional Flow Reserve Workshop
Cardiovacular Research Technologies
Aortic Valve Treatment in Extensive Ascending Aortic Calcification
Figure 5 TAVI with a self-expanding valve in
Perventricular device closure of perimembranous ventricular septal defects in 61 young children: Early and midterm follow-up results  Kaiyu Tao, MD, Ke.
Samir R. Kapadia, MD On behalf of The PARTNER Trial Investigators
Minimally invasive transthoracic device closure of isolated ventricular septal defects without cardiopulmonary bypass: Long-term follow-up results  Quansheng.
Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial Michael J. Mack, MD.
Karim A. Diab, MD, Ziyad M. Hijazi, MD, Qi-Ling Cao, MD, Emile A
Clinical course of participants with high cardiovascular risk profile
Sagit Ben Zekry et al. JIMG 2008;1:
Jamil Aboulhosn et al. JCIN 2017;10:53-63
Charanjit S. Rihal et al. JCIN 2012;5:
A 58-year-old woman with aortic stenosis investigated by echocardiography and CT. (A) Doppler echocardiography demonstrating a peak aortic valve (AV) velocity.
Structural Heart Live Cases
Presentation transcript:

Paravalvular Leak Closure Case Presentation Samir Kapadia, MD Professor of Medicine Director, Cardiac Catheterization Laboratories Cleveland Clinic DISCLOSURE : NONE

Samir Kapadia, MD I have no real or apparent conflicts of interest to report. My presentation will include off label discussions: Valves

Clinical Presentation 79 year old lady s/p St. Jude #19 AV in 1990 s/p St. Jude # 23 MV in 2004 with CABG (L-AD and SVG to OM) AF, DDD pacemaker Severe hemolytic anemia worsening over last 1 year. 30 blood transfusions last year. 8 in last 2 months. Class III CHF (gets SOB moving from chair to chair) Question of aortic valve leaflet dysfunction

Echocardiogram TTE EF – normal (55%) AV – gradient p/m = 9/5 mm Hg MV – gradient p/m = 20/8 mm Hg RVSP = 62 mm Hg TEE (difficult to pass a probe, esophageal stricture, needed direct visualization with scope to pass the probe) 3+ MR paravalvular

TEE

Labs Blood cultures (-) LDH = 3618 U/L AST = 166 U/L T Bili 1.9 mg/dL Haptoglobin <20 mg/dL BNP = 443 pg/mL

Procedure Conscious sedation Image fusion and planning of the procedure stiff wire in LV will not exteriorize if needed TA puncture

Approaches to PVL Closure Kapadia and Tuzcu, Circ Cardiovasc Interv 2011;4;308-310

Procedure Conscious sedation Image fusion and planning of the procedure stiff wire in LV will not exteriorize if needed TA puncture Assessment of valves and coronaries Initial procedure with fluoro and ICE Pediatric probe

Where is the Leak? Foster GP et al, Ann Thorac Surg 1998; 65:1025–1031

Biplane TEE

CTA

Marking of Area of Interest: Aortic Root

Marking of Area of Interest: Leak

Marking of Area of Interest: TS Puncture

Rotational CT in Cath Lab

Fusion

Markings on the Fluoro

Checking Valve Motion

Transseptal Puncture

Hemodynamics Mean LA = 24 mm Hg, V wave = 44 mm Hg

Crossing the Defect

No Gradient Across AS

Advancing the Delivery Sheath

Attempt at Deploying Muscular VSD Device

TEE with Deployment

Interference with Disc

Doppler Gradients Before Deployment With Deployment

Deployment of PDA Device

PDA Device

Gradients Unchanged Before After

Functioning Valve After Release

LA pressure Before Deployment With Deployment Mean LA = 24 mm Hg, V wave = 44 mm Hg Mean LA = 18 mm Hg, V wave = 30 mm Hg

F/u Labs Day Prior Post Day 1 LDH = 3618 U/L AST = 166 U/L T Bili 1.9 mg/dL Haptoglobin <20 mg/dL BNP = 443 pg/mL LDH = 2303 U/L AST = 80 U/L T Bili 1.3 mg/dL Haptoglobin <20 mg/dL one month Hg = 10.4

Thank YOU For ATTENTION